Dr. Sarfraz Aly, MD
What this data tells you about Dr. Aly
Dr. Sarfraz Aly is an internal medicine in Sugar Land, TX, with 17 years in practice. Based on federal Medicare data, Dr. Aly performed 23,920 Medicare services across 2,736 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aly received a total of $16,370 from 48 pharmaceutical and/or device companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aly is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, dalbavancin, 5 mg | 8,500 | $11 | $40 |
| Inclisiran injection (Leqvio) for cholesterol | 7,952 | $9 | $34 |
| Hospital follow-up visit, moderate complexity | 4,761 | $60 | $200 |
| Office visit, established patient (30-39 min) | 700 | $95 | $253 |
| Initial hospital admission, high complexity | 676 | $131 | $388 |
| Initial hospital admission, moderate complexity | 318 | $98 | $275 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 125 | $30 | $86 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 116 | $41 | $143 |
| Office visit, established patient, complex (40-54 min) | 105 | $119 | $354 |
| Hospital discharge management, 30+ min | 97 | $88 | $206 |
| New patient office visit (45-59 min) | 95 | $123 | $327 |
| Hospital follow-up visit, high complexity | 94 | $90 | $300 |
| Removal of skin and tissue, 20.0 sq cm or less | 76 | $41 | $255 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 56 | $110 | $458 |
| Office visit, established patient (20-29 min) | 46 | $67 | $183 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 41 | $46 | $225 |
| Drug injection, under skin or into muscle | 36 | $11 | $48 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 29 | $41 | $103 |
| Removal of tunneled central venous tube | 23 | $126 | $328 |
| New patient office visit, complex (60-74 min) | 22 | $160 | $432 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 22 | $31 | $82 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 18 | $102 | $251 |
| Nursing facility discharge management, more than 30 minutes | 12 | $100 | $204 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Aly is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 6%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Aly experienced with injection, dalbavancin, 5 mg?
Does Dr. Aly receive payments from pharmaceutical companies?
How do Dr. Aly's costs compare to other internal medicines in Sugar Land?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology